Calendar

Thursday Jun 19,2025
Estimate Eps
Actual Eps
Eps Surprise
Estimate Revenue
Actual Revenue
Revenue Surprise
Period
logo
SNOA
Sonoma Pharmaceuticals
--
-0.48 USD
--
4.44M USD
3.75M USD
-15.54%
Q4 2025
Backtest
The backtest results reveal that SNOA experiences a low short-term success rate of 27.27% within three days after an earnings miss, but shows a modest rebound with a 5.19% average return over 30 days and a 45.45% win rate. Meanwhile, the broader Health Care Equipment & Supplies industry displays minimal reaction to earnings misses, with a peak return of only 3.94%. This contrast suggests that although immediate responses to SNOA’s earnings miss are negative, there are opportunities for gains with a patient investment approach, unlike the general industry where earnings misses do not present clear trading advantages.